InvestorsHub Logo
Followers 826
Posts 119569
Boards Moderated 14
Alias Born 09/05/2002

Re: DewDiligence post# 683

Friday, 01/14/2022 1:48:26 PM

Friday, January 14, 2022 1:48:26 PM

Post# of 751
FDA approves Rinvoq for second-line atopic dermatitis:

https://finance.yahoo.com/news/u-fda-approves-rinvoq-upadacitinib-181000896.html

The approval includes both dose strengths (15mg and 30mg qD).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ABBV News